This week we look at how changes to accelerated approvals at the Food and Drug Administration are affecting drug approvals. Also, there is news of CVS’s foray into clinical trials, the end of the public health emergency for COVID-19, and the costs of the Supreme Court not hearing a case involving generic drugs. … READ MORE >